Renaissance Technologies
OKYO

Renaissance Technologies’s OKYO Pharma OKYO Stock Holding History

Renaissance Technologies’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8K Buy
+11,200
New +$17.9K ﹤0.01% 3103
2026
Q1 		– Sell
-138,000
Closed -$286K – 3560
2025
Q4 		$286K Buy
138,000
+96,800
+235% +$210K ﹤0.01% 2780
2025
Q3 		$82.4K Buy
+41,200
New +$105K ﹤0.01% 3278
2025
Q2 		– Sell
-13,946
Closed -$17.7K – 3798
2025
Q1 		$17.7K Sell
13,946
-2,554
-15% -$3.06K ﹤0.01% 3365
2024
Q4 		$19K Buy
+16,500
New +$17.7K ﹤0.01% 3486
2024
Q1 		– Sell
-11,800
Closed -$21K – 3963
2023
Q4 		$21K Sell
11,800
-4,547
-28% -$7.98K ﹤0.01% 3574
2023
Q3 		$30K Buy
+16,347
New +$27.5K ﹤0.01% 3470

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Renaissance Technologies's OKYO Position: Q2 2026 in Review

Renaissance Technologies opened a new position in OKYO Pharma (OKYO) in Q2 2026: 11,200 shares worth $16.8K. The stake represents ﹤0.01% of the portfolio and ranks #3103 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in OKYO as recently as Q4 2025.

Renaissance Technologies first reported a position in OKYO in Q3 2023 and has held it in 7 quarters since. The position peaked at $286K in Q4 2025. 19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

  • Renaissance Technologies held 11,200 shares of OKYO Pharma worth $16.8K as of Q2 2026.
  • OKYO Pharma was a new Renaissance Technologies position in Q2 2026.
  • OKYO Pharma made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3103 holding.
  • Renaissance Technologies first reported a position in OKYO Pharma in Q3 2023 and has held it in 7 quarters since.
  • Renaissance Technologies's OKYO Pharma position peaked at $286K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.